Remifentanil 5 MG Injection — RxCUI 1729710
RxNorm drug concept · Semantic clinical drug
RxCUI 1729710
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1729710
Official nameRemifentanil 5 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asremifentanil (as remifentanil hydrochloride) 5 MG Injection
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)806 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Remifentanil: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Remifentanil is a specialized opioid used only in surgery and closely monitored settings. It works within seconds and wears off within minutes, which gives your anesthesia team pre...
- Why am I getting remifentanil instead of a regular pain medicine?
- Remifentanil controls pain but cannot put you to sleep on its own, so it is always used together with other anesthetics that do cause unconsciousness. Your team combines it with me...
- Will I be awake or remember anything during surgery if I'm given this?
🕸️ Concept Web — How Remifentanil 5 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Remifentanil 5 MG Injection
RxCUI 1729710 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Remifentanil
73032IN
-
Remifentanil
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ultiva
153379BN
-
Ultiva
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Remifentanil Injection
1729577SCDF -
Remifentanil Injectable Product
1157406SCDG -
Remifentanil Injection [Ultiva]
1729580SBDF -
Ultiva Injectable Product
1187691SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Remifentanil Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Remifentanil 5 MG
1729709SCDC -
Remifentanil 5 MG Injection [Ultiva]
1729712SBD -
Remifentanil 5 MG [Ultiva]
1729711SBDC
-
Remifentanil 5 MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Remifentanil 5 MG
SCDC · 1729709 -
Remifentanil Injection
SCDF · 1729577 -
Remifentanil Injectable Product
SCDG · 1157406
Brand-Name Concepts
-
Remifentanil 5 MG Injection [Ultiva]
SBD · 1729712 -
Remifentanil 5 MG [Ultiva]
SBDC · 1729711 -
Remifentanil Injection [Ultiva]
SBDF · 1729580 -
Ultiva Injectable Product
SBDG · 1187691 -
Ultiva
BN · 153379
📦 FDA Products & Package NDCs
12 products · 12 package NDCs
12 package NDCs map to RxCUI 1729710 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9391-10 | 10 VIAL in 1 CARTON (0143-9391-10) / 3 mL in 1 VIAL (0143-9... | REMIFENTANIL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 2021-05-15 |
| 00143-9392-10 | 10 VIAL in 1 CARTON (0143-9392-10) / 5 mL in 1 VIAL (0143-9... | REMIFENTANIL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 2021-05-15 |
| 00143-9393-10 | 10 VIAL in 1 CARTON (0143-9393-10) / 10 mL in 1 VIAL (0143-... | REMIFENTANIL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 2021-05-15 |
| 63323-0723-03 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-03) / 3 mL in 1... | Remifentanil Hydrochloride | Fresenius Kabi USA, LLC | 2018-01-19 |
| 63323-0724-05 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-724-05) / 5 mL in 1... | Remifentanil Hydrochloride | Fresenius Kabi USA, LLC | 2018-01-19 |
| 63323-0725-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-725-10) / 10 mL in... | Remifentanil Hydrochloride | Fresenius Kabi USA, LLC | 2018-01-19 |
| 67457-0912-01 | 10 VIAL, GLASS in 1 CARTON (67457-912-01) / 3 mL in 1 VIAL,... | Ultiva | Mylan Institutional LLC | 2020-04-15 |
| 67457-0913-02 | 10 VIAL, GLASS in 1 CARTON (67457-913-02) / 5 mL in 1 VIAL,... | Ultiva | Mylan Institutional LLC | 2020-04-15 |
| 67457-0914-05 | 10 VIAL, GLASS in 1 CARTON (67457-914-05) / 10 mL in 1 VIAL... | Ultiva | Mylan Institutional LLC | 2020-04-15 |
| 72078-0034-01 | 10 VIAL, GLASS in 1 CARTON (72078-034-01) / 3 mL in 1 VIAL,... | Ultiva | Mylan Institutional LLC | 2023-06-21 |
| 72078-0035-02 | 10 VIAL, GLASS in 1 CARTON (72078-035-02) / 5 mL in 1 VIAL,... | Ultiva | Mylan Institutional LLC | 2023-09-18 |
| 72078-0036-05 | 10 VIAL, GLASS in 1 CARTON (72078-036-05) / 10 mL in 1 VIAL... | Ultiva | Mylan Institutional LLC | 2024-12-16 |
Observed labelers:
Mylan Institutional LLC (6) ·
Fresenius Kabi USA, LLC (3) ·
Hikma Pharmaceuticals USA Inc. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.